LAG3 + Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1 + Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis

Immunity

Volumn 49, Issue 2, 2018, Pages 342-352.e5

  Bauché, David ^a   Joyce Shaikh, Barbara ^a   Jain, Renu ^a   Grein, Jeff ^a   Ku, Karin S ^a   Blumenschein, Wendy M ^a   Ganal Vonarburg, Stephanie C ^b   Wilson, Douglas C ^a   McClanahan, Terrill K ^a   Malefyt, Rene de Waal ^a   Macpherson, Andrew J ^b   Annamalai, Lakshmanan ^a   Yearley, Jennifer H ^a   Cua, Daniel J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; LATENT ACTIVATION GENE 3; PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; CD223 ANTIGEN; CX3CR1 PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; HLA ANTIGEN CLASS 2; IL10 PROTEIN, MOUSE; IL1B PROTEIN, MOUSE; IL23A PROTEIN, MOUSE; INTERLEUKIN 10; INTERLEUKIN 23P19; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; LEUKOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; COLITIS; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY BOWEL DISEASE; INTERPERSONAL COMMUNICATION; INTESTINE MACROPHAGE; INTESTINE MUCOSA; LYMPHOID CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SECOND CERVICAL VERTEBRA; ANIMAL; C57BL MOUSE; CELL CULTURE; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD; CELLS, CULTURED; COLITIS; CX3C CHEMOKINE RECEPTOR 1; DENDRITIC CELLS; FORKHEAD TRANSCRIPTION FACTORS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; INTESTINAL MUCOSA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES, REGULATORY;

EID: 85051681747     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2018.07.007     Document Type: Article

References (59)

1. Anderson, A.C., Joller, N., Kuchroo, V.K., Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation. Immunity 44 (2016), 989–1004.
2. Andreae, S., Buisson, S., Triebel, F., MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223). Blood 102 (2003), 2130–2137.
3. Andrews, L.P., Marciscano, A.E., Drake, C.G., Vignali, D.A., LAG3 (CD223) as a cancer immunotherapy target. Immunol. Rev. 276 (2017), 80–96.
4. Aparicio-Domingo, P., Romera-Hernandez, M., Karrich, J.J., Cornelissen, F., Papazian, N., Lindenbergh-Kortleve, D.J., Butler, J.A., Boon, L., Coles, M.C., Samsom, J.N., Cupedo, T., Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage. J. Exp. Med. 212 (2015), 1783–1791.
5. Aychek, T., Mildner, A., Yona, S., Kim, K.W., Lampl, N., Reich-Zeliger, S., Boon, L., Yogev, N., Waisman, A., Cua, D.J., Jung, S., IL-23-mediated mononuclear phagocyte crosstalk protects mice from Citrobacter rodentium-induced colon immunopathology. Nat. Commun., 6, 2015, 6525.
6. Barrett, J.C., Hansoul, S., Nicolae, D.L., Cho, J.H., Duerr, R.H., Rioux, J.D., Brant, S.R., Silverberg, M.S., Taylor, K.D., Barmada, M.M., et al. NIDDK IBD Genetics Consortium Belgian-French IBD Consortium, Wellcome Trust Case Control Consortium. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40 (2008), 955–962.
7. Brand, S., Beigel, F., Olszak, T., Zitzmann, K., Eichhorst, S.T., Otte, J.M., Diepolder, H., Marquardt, A., Jagla, W., Popp, A., et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006), G827–G838.
8. Brugiroux, S., Beutler, M., Pfann, C., Garzetti, D., Ruscheweyh, H.J., Ring, D., Diehl, M., Herp, S., Lötscher, Y., Hussain, S., et al. Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium. Nat. Microbiol., 2, 2016, 16215.
9. Buisson, S., Triebel, F., MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells. Vaccine 21 (2003), 862–868.
10. Buonocore, S., Ahern, P.P., Uhlig, H.H., Ivanov, I.I., Littman, D.R., Maloy, K.J., Powrie, F., Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464 (2010), 1371–1375.
11. Camisaschi, C., Casati, C., Rini, F., Perego, M., De Filippo, A., Triebel, F., Parmiani, G., Belli, F., Rivoltini, L., Castelli, C., LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites. J. Immunol. 184 (2010), 6545–6551.
12. Castelli, C., Triebel, F., Rivoltini, L., Camisaschi, C., Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity. OncoImmunology, 3, 2014, e967146.
13. Chang, S.Y., Song, J.H., Guleng, B., Cotoner, C.A., Arihiro, S., Zhao, Y., Chiang, H.S., O'Keeffe, M., Liao, G., Karp, C.L., et al. Circulatory antigen processing by mucosal dendritic cells controls CD8(+) T cell activation. Immunity 38 (2013), 153–165.
14. Chaudhry, A., Samstein, R.M., Treuting, P., Liang, Y., Pils, M.C., Heinrich, J.M., Jack, R.S., Wunderlich, F.T., Brüning, J.C., Müller, W., Rudensky, A.Y., Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34 (2011), 566–578.
15. Coombes, J.L., Siddiqui, K.R., Arancibia-Cárcamo, C.V., Hall, J., Sun, C.M., Belkaid, Y., Powrie, F., A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204 (2007), 1757–1764.
16. Duerr, R.H., Taylor, K.D., Brant, S.R., Rioux, J.D., Silverberg, M.S., Daly, M.J., Steinhart, A.H., Abraham, C., Regueiro, M., Griffiths, A., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (New York, N.Y 314 (2006), 1461–1463.
17. Eken, A., Singh, A.K., Treuting, P.M., Oukka, M., IL-23R+ innate lymphoid cells induce colitis via interleukin-22-dependent mechanism. Mucosal Immunol. 7 (2014), 143–154.
18. Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., Fujiyama, Y., Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52 (2003), 65–70.
19. Gagliani, N., Magnani, C.F., Huber, S., Gianolini, M.E., Pala, M., Licona-Limon, P., Guo, B., Herbert, D.R., Bulfone, A., Trentini, F., et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 19 (2013), 739–746.
20. Glas, J., Seiderer, J., Bayrle, C., Wetzke, M., Fries, C., Tillack, C., Olszak, T., Beigel, F., Steib, C., Friedrich, M., et al. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease. PLoS ONE, 6, 2011, e29309.
21. Hemon, P., Jean-Louis, F., Ramgolam, K., Brignone, C., Viguier, M., Bachelez, H., Triebel, F., Charron, D., Aoudjit, F., Al-Daccak, R., Michel, L., MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis. J. Immunol. 186 (2011), 5173–5183.
22. Hepworth, M.R., Monticelli, L.A., Fung, T.C., Ziegler, C.G., Grunberg, S., Sinha, R., Mantegazza, A.R., Ma, H.L., Crawford, A., Angelosanto, J.M., et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498 (2013), 113–117.
23. Hepworth, M.R., Fung, T.C., Masur, S.H., Kelsen, J.R., McConnell, F.M., Dubrot, J., Withers, D.R., Hugues, S., Farrar, M.A., Reith, W., et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells. Science (New York, N.Y 348 (2015), 1031–1035.
24. Huang, C.T., Workman, C.J., Flies, D., Pan, X., Marson, A.L., Zhou, G., Hipkiss, E.L., Ravi, S., Kowalski, J., Levitsky, H.I., et al. Role of LAG-3 in regulatory T cells. Immunity 21 (2004), 503–513.
25. Josefowicz, S.Z., Niec, R.E., Kim, H.Y., Treuting, P., Chinen, T., Zheng, Y., Umetsu, D.T., Rudensky, A.Y., Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482 (2012), 395–399.
26. Kim, S.V., Xiang, W.V., Kwak, C., Yang, Y., Lin, X.W., Ota, M., Sarpel, U., Rifkin, D.B., Xu, R., Littman, D.R., GPR15-mediated homing controls immune homeostasis in the large intestine mucosa. Science (New York, N.Y 340 (2013), 1456–1459.
27. Kinnebrew, M.A., Buffie, C.G., Diehl, G.E., Zenewicz, L.A., Leiner, I., Hohl, T.M., Flavell, R.A., Littman, D.R., Pamer, E.G., Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 36 (2012), 276–287.
28. Kiss, E.A., Diefenbach, A., Role of the Aryl Hydrocarbon Receptor in Controlling Maintenance and Functional Programs of RORγt(+) Innate Lymphoid Cells and Intraepithelial Lymphocytes. Front. Immunol., 3, 2012, 124.
29. Koscsó B., Gowda, K., Bogunovic, M., In vivo depletion and genetic targeting of mouse intestinal CX3CR1(+) mononuclear phagocytes. J. Immunol. Methods 432 (2016), 13–23.
30. Kouo, T., Huang, L., Pucsek, A.B., Cao, M., Solt, S., Armstrong, T., Jaffee, E., Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells. Cancer Immunol. Res. 3 (2015), 412–423.
31. Lakatos, P.L., Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. World J. Gastroenterol. 12 (2006), 6102–6108.
32. Li, L.J., Gong, C., Zhao, M.H., Feng, B.S., Role of interleukin-22 in inflammatory bowel disease. World J. Gastroenterol. 20 (2014), 18177–18188.
33. Li, H., Limenitakis, J.P., Fuhrer, T., Geuking, M.B., Lawson, M.A., Wyss, M., Brugiroux, S., Keller, I., Macpherson, J.A., Rupp, S., et al. The outer mucus layer hosts a distinct intestinal microbial niche. Nat. Commun., 6, 2015, 8292.
34. Liang, B., Workman, C., Lee, J., Chew, C., Dale, B.M., Colonna, L., Flores, M., Li, N., Schweighoffer, E., Greenberg, S., et al. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J. Immunol. 180 (2008), 5916–5926.
35. Loftus, E.V. Jr., Management of extraintestinal manifestations and other complications of inflammatory bowel disease. Curr. Gastroenterol. Rep. 6 (2004), 506–513.
36. Longman, R.S., Diehl, G.E., Victorio, D.A., Huh, J.R., Galan, C., Miraldi, E.R., Swaminath, A., Bonneau, R., Scherl, E.J., Littman, D.R., CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med. 211 (2014), 1571–1583.
37. Maloy, K.J., Salaun, L., Cahill, R., Dougan, G., Saunders, N.J., Powrie, F., CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197 (2003), 111–119.
38. Manta, C., Heupel, E., Radulovic, K., Rossini, V., Garbi, N., Riedel, C.U., Niess, J.H., CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol. 6 (2013), 177–188.
39. Mazzini, E., Massimiliano, L., Penna, G., Rescigno, M., Oral tolerance can be established via gap junction transfer of fed antigens from CX3CR1⁺ macrophages to CD103⁺ dendritic cells. Immunity 40 (2014), 248–261.
40. Mortha, A., Chudnovskiy, A., Hashimoto, D., Bogunovic, M., Spencer, S.P., Belkaid, Y., Merad, M., Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science, 343, 2014, 1249288.
41. Niess, J.H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B.A., Vyas, J.M., Boes, M., Ploegh, H.L., Fox, J.G., et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307 (2005), 254–258.
42. Ouyang, W., Kolls, J.K., Zheng, Y., The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28 (2008), 454–467.
43. Pardoll, D.M., The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12 (2012), 252–264.
44. Parks, O.B., Pociask, D.A., Hodzic, Z., Kolls, J.K., Good, M., Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease. Front. Cell Dev. Biol., 3, 2016, 85.
45. Pearson, C., Thornton, E.E., McKenzie, B., Schaupp, A.L., Huskens, N., Griseri, T., West, N., Tung, S., Seddon, B.P., Uhlig, H.H., Powrie, F., ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation. eLife, 5, 2016, e10066.
46. Rolink, A., Melchers, F., Andersson, J., The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity 5 (1996), 319–330.
47. Rossini, V., Zhurina, D., Radulovic, K., Manta, C., Walther, P., Riedel, C.U., Niess, J.H., CX3CR1⁺ cells facilitate the activation of CD4 T cells in the colonic lamina propria during antigen-driven colitis. Mucosal Immunol. 7 (2014), 533–548.
48. Rubtsov, Y.P., Rasmussen, J.P., Chi, E.Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W.R. Jr., et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28 (2008), 546–558.
49. Satoh-Takayama, N., Serafini, N., Verrier, T., Rekiki, A., Renauld, J.C., Frankel, G., Di Santo, J.P., The chemokine receptor CXCR6 controls the functional topography of interleukin-22 producing intestinal innate lymphoid cells. Immunity 41 (2014), 776–788.
50. Schulz, O., Jaensson, E., Persson, E.K., Liu, X., Worbs, T., Agace, W.W., Pabst, O., Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J. Exp. Med. 206 (2009), 3101–3114.
51. Sefik, E., Geva-Zatorsky, N., Oh, S., Konnikova, L., Zemmour, D., McGuire, A.M., Burzyn, D., Ortiz-Lopez, A., Lobera, M., Yang, J., et al. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science 349 (2015), 993–997.
52. Shan, M., Gentile, M., Yeiser, J.R., Walland, A.C., Bornstein, V.U., Chen, K., He, B., Cassis, L., Bigas, A., Cols, M., et al. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science 342 (2013), 447–453.
53. Silberger, D.J., Zindl, C.L., Weaver, C.T., Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity. Mucosal Immunol. 10 (2017), 1108–1117.
54. Sonnenberg, G.F., Fouser, L.A., Artis, D., Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12 (2011), 383–390.
55. Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A.K., Blumberg, R.S., Xavier, R.J., Mizoguchi, A., IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118 (2008), 534–544.
56. Vignali, D.A., Collison, L.W., Workman, C.J., How regulatory T cells work. Nature reviews 8 (2008), 523–532.
57. Vonarbourg, C., Mortha, A., Bui, V.L., Hernandez, P.P., Kiss, E.A., Hoyler, T., Flach, M., Bengsch, B., Thimme, R., Hölscher, C., et al. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity 33 (2010), 736–751.
58. Zenewicz, L.A., Yancopoulos, G.D., Valenzuela, D.M., Murphy, A.J., Stevens, S., Flavell, R.A., Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29 (2008), 947–957.
59. Zigmond, E., Bernshtein, B., Friedlander, G., Walker, C.R., Yona, S., Kim, K.W., Brenner, O., Krauthgamer, R., Varol, C., Müller, W., Jung, S., Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity 40 (2014), 720–733.